{{Rsnum
|rsid=2117032
|Chromosome=12
|position=20921188
|Orientation=plus
|GMAF=0.4784
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.8 | 53.8 | 35.4
| HCB | 20.0 | 57.8 | 22.2
| JPT | 22.7 | 38.6 | 38.6
| YRI | 96.8 | 3.2 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 20.0 | 57.8 | 22.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19419973
|Trait=Bilirubin levels
|Title=Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia
|RiskAllele=C
|Pval=3E-14
|OR=0.13
|ORtxt=[0.08-0.18] SD increase
|OA=1
}}

{{PharmGKB
|RSID=rs2117032
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19419973
|Annotation=This variant is downstream of the 3' UTR of the SLCO1B3 and associated with bilirubin levels in a genome wide association scan from 4300 Sardinian individuals. Each copy of the minor allele C was responsible, on average, for an increase of 0.048 mg/dl in bilirubin levels.
|Drugs=
|Drug Classes=
|Diseases=Hyperbilirubinemia
|Curation Level=Curated
|PharmGKB Accession ID=PA164758017
}}
{{PMID Auto
|PMID=20639394
|Title=Genome-wide association of serum bilirubin levels in Korean population
|OA=1
}}

{{PMID Auto
|PMID=22580719
|Title=UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms versus neonatal hyperbilirubinemia: is there an association?
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2117032
|overall_frequency_n=50
|overall_frequency_d=128
|overall_frequency=0.390625
|n_genomes=27
|n_genomes_annotated=0
|n_haplomes=38
|n_articles=1
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}